Androgen deprivation therapy in Turkey typically costs from AUD $2,107 to AUD $3,512, depending on the specific hormone protocols, clinic location, and diagnostic requirements. In Australia, patients often face average costs of around AUD $8,007, meaning those travelling to Turkey can save approximately 65%. Standard packages usually include oncologist consultations, initial blood panels, and patient coordination services in medical hubs like Istanbul, Antalya, and Bursa.
Bookimed Expert Insight: Australian patients gain significant value at institutions like Anadolu Medical Center, which is affiliated with Johns Hopkins Hospital. This connection allows access to American-standard oncology protocols at Turkish price points. Specialist doctors such as Professor Necdet Uskent and Dr. Eda Tanrikulu hold European Medical Oncology certificates, ensuring that the lower cost does not compromise the clinical rigour required for complex hormone therapy.
| Turkey | Thailand | ||
| Androgen deprivation therapy | from AUD $2,107 | from AUD $2,107 | from AUD $2,528 |
Professor Mustafa Solak completed a fellowship at the University of Texas MD Anderson Cancer Center – consistently ranked as the top cancer hospital globally. He leads oncology care at Hisar Hospital Intercontinental.
Dr. Ilker Tinay is an urological oncologist at Anadolu Medical Center. He sits on the Executive Board of the Association of Urooncology. Dr. Tinay specializes in minimally invasive surgery and neo-bladder reconstruction. He works at Anadolu, a Top 10 global hospital according to MTQUA. The center is also affiliated with Johns Hopkins Medicine.
Dr. Onder Surgit is a professor of general surgery at Optimed International Hospital. He is a surgical instructor at the Advanced Medical Technologies Training Center (ITEM). Dr. Surgit treats cancer, obesity, and complex gastrointestinal conditions. He applies laparoscopic techniques for weight loss and tumor removal.
Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.
Androgen deprivation therapy (ADT) is a hormone treatment used in Turkey. It treats prostate cancer by lowering testosterone levels. Prostate cancer cells rely on male hormones to grow. So, this therapy slows tumour progression and is often used alongside radiotherapy. It is also used for advanced metastatic cases.
Bookimed Expert Insight: Turkish oncology centres like Medical Park Göztepe provide integrated ADT within dedicated chemotherapy units. They often combine hormone therapy with technologies like TrueBeam STx. This multi-modal approach is typically A$4,000–A$5,000 cheaper than similar private protocols. These protocols are used in Australian metropolitan hospitals.
Patient Consensus: Patients in Turkey find the therapy effectively slows cancer growth. It also makes radiation more successful. They value clear guidance on managing side effects like fatigue and mood changes during treatment.
Doctors manage androgen deprivation therapy (ADT) side effects by monitoring testosterone-related changes to bone density, metabolic health, and emotional well-being. Specialists at JCI-accredited Turkish centres typically use non-hormonal medications, supervised exercise plans, and targeted bone-strengthening therapies. This helps maintain patient quality of life during prostate cancer treatment.
Bookimed Expert Insight: Bookimed data shows that leading Turkish oncology centres, such as Anadolu Medical Center, are affiliated with top-tier institutions like Johns Hopkins. This means patients receive the same side-effect management protocols used in the US. However, costs typically range from $1,500 to $2,500.
Patient Consensus: Patients in Turkey report that while hot flushes and fatigue are common, staying active with resistance training significantly helps preserve muscle strength. Many noted that mental health support was vital for managing unexpected mood changes and brain fog during therapy.
Turkish oncologists administer androgen deprivation therapy (ADT) via intramuscular injections, subcutaneous injections, and oral tablets. Surgical castration is also an option. Major Istanbul centres like Anadolu Medical Center and Medical Park Göztepe provide these systemic treatments. They suppress testosterone for prostate cancer management, often using JCI-accredited protocols.
Bookimed Expert Insight: Anadolu Medical Center is affiliated with Johns Hopkins. The centre often integrates ADT with PET-CT PSMA scans for precision monitoring. This high-volume centre treats 65,000+ patients annually. Patients can access the same oncology protocols found in Australia. However, they typically save over 84% on total procedure costs.
Patient Consensus: Patients in Turkey find the depot injections convenient for long-term care. They suggest warming oil-based medications and rotating injection sites to improve comfort. Most appreciate the availability of fine needles and pen devices for less painful subcutaneous delivery.
Istanbul serves as the primary medical hub for prostate cancer care in Turkey. It holds the highest concentration of JCI-accredited facilities and specialist uro-oncologists. Ankara follows as a major academic referral centre. Antalya offers structured oncology care for patients seeking a recovery-focused environment.
Bookimed Expert Insight: Istanbul dominates private medical tourism. However, Ankara remains the critical hub for complex, long-term oncology management. Leading centres like Medipol Mega in Istanbul serve over 200,000 patients annually. This shows the high-volume experience needed to manage systemic treatments like ADT effectively.
Patient Consensus: Istanbul is the most popular choice for private specialist access and modern hospital environments. Ankara is highly regarded for its top healthcare professionals and its dedicated oncology facilities. These facilities handle serious cancer management in Turkey.